DB11643ApprovedInvestigationalProtein Based Therapies
Recombinant Cholera Toxin B Subunit is an ingredient in the EMA-authorised product Dukoral.
- First approval
- Canada, 2010 · European Union, 2022
- Also known as
- Cholera enterotoxin B chain · Cholera enterotoxin subunit B · Choleragenoid
- Brand names
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 21, 2026
Which companies are running trials of Recombinant Cholera Toxin B Subunit, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account